A new blood test, developed by a Raleigh company, can more accurately predict a patient's risk of heart disease than normal cholesterol tests. A Raleigh-based company has developed a new blood test ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE:LH) and LipoScience, Inc. (NASDAQ:LPDX), a provider of specialized cardiovascular diagnostic ...

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical tests using nuclear magnetic resonance (NMR) ...

Lab testing giant LabCorp, which is based in Burlington, is acquiring Raleigh-based LipoScience in a deal worth some $85 million in cash. Shares in LipoScience, which provides testing services related ...

The Vantera Clinical Analyzer can identify and quantify concentrations of lipoproteins using NMR spectroscopy and proprietary signal processing algorithms. Such analysis provides physicians and ...

RALEIGH, N.C. – LipoScience, Inc. has entered into an agreement with ARUP Laboratories, a national clinical and anatomic pathology laboratory, to offer its proprietary NMR LipoProfile test. ARUP ...

Raleigh, NC, March 28, 2008 - The American Diabetes Association (ADA) and the American College of Cardiology (ACC) issued a consensus statement today that states the measurement of LDL particle number ...

Diagnostics company LipoScience aims to become North Carolina’s next public company. LipoScience plans to use proceeds from its stock offering to expand its sales and marketing and fund continued R&D ...

Diagnostics firm LipoScience is seeking U.S. Food and Drug Administration clearance for a new lab-based technology platform that tests for heart disease risks. LipoScience has commercialized a blood ...

A new blood test, developed by a Raleigh company, can more accurately predict a patient's risk of heart disease than normal cholesterol tests. A Raleigh-based company has developed a new blood test ...